Cite Filings / FDMT / 0000950170-23-020703

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

4D Molecular Therapeutics, Inc. Filed 2023-05-11 Acc 0000950170-23-020703

Documents 1

10-Q Quarterly Report , fdmt-20230331.htm

Around this filing

2023-08-09 10-Q Quarterly Report
2023-05-11 4 10% owner bought 850,000 shares at $16.00 ($13,600,000)
2023-05-11 10-Q Quarterly Report
2023-05-11 8-K Results of operations
2023-05-09 8-K Other events
2023-05-08 424B5 Prospectus
2022-11-08 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading fdmt-20230331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…